CASGEVY® is a groundbreaking gene therapy for sickle cell disease, offering patients a chance to live free from severe vaso-occlusive crises by using their own modified blood stem cells.

Basic information

Country

USA

Group Name

Vertex Pharmaceuticals

Source

Source